Title : Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment.

Pub. Date : 2020 Feb

PMID : 31744897






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combined AZD8055 and cisplatin treatment resulted in effective mTORC1/2 inhibition, increased caspase-3 activity, and enhanced tumor growth inhibition. Cisplatin caspase 3 Homo sapiens